The development and validation of models of human skin diseases for drug testing

The development and validation of models of human skin diseases for drug testing - disease models

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON38558

Enrollment

Registered

2013-06-03

Start date

2013-10-01

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Developing human skin disease models atopic dermatitis psoriasis vitiligo

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Volunteers (male/female) are 18 years or older, suffering from psoriasis vulgaris, vitiligo or atopic dermatitis.

Exclusion criteria

Exclusion criteria: Volunteers cannot be taking immune-modulating drugs. Volunteers cannot have UV/light therapy. If donating lesional skin biopsies then patients cannot use topical treatments up to 2 weeks before donating the biopsies (they can use placebo creams to treat dry skin). Volunteers should not have problems with the Köbner phenomenom. Volunteers should not be pregnant

Design outcomes

Primary

Measure	Time frame
N.A.	—

Secondary

Measure	Time frame
N.A.	—

Countries

Netherlands

Outcome results